Iodine povacrylex API Manufacturers

compare suppliers & get competitive offers



Selected filters:

Production region




To view suppliers for this material, you need to be logged in first.






This is because of international laws regarding narcotic materials. Furthermore, the contents of this page are only accessible if you are professionaly active in the pharmaceutical industry. In case you are, it is possible to register on our platform, and after your account is approved by our team you will be able to view suppliers and send your request.



Looking for Iodine povacrylex API ?

Here you will find a list of producers, manufacturers and traders of Iodine povacrylex. You can sort by certificates such as GMP, FDA, CEP, Written Confirmation and more. Send inquiries for free and get in direct contact with the supplier of your choice.
API | Excipient name:
Iodine povacrylex 
Cas Number:
DrugBank number:
Unique Ingredient Identifier:

About Iodine povacrylex

Here is a short description about Iodine povacrylex. Iodine povacrylex (DuraPrep) is a surgical solution, film-forming iodophor complex that provides fast acting, persistent, broad-spectrum antimicrobial activity. DuraPrep solution is indicated for use as a patient preoperative skin preparation, for the preparation of the skin prior to surgery and to help reduce bacteria

Ask the supplier for a certificate of analysis to find out more about the quality of Iodine povacrylex.

Iodine povacrylex is a type of Antimicrobial agents

Antimicrobial agents are a vital subcategory within the pharmaceutical industry, specifically developed to combat microbial infections. These agents, also known as antibiotics, play a crucial role in treating various types of bacterial, fungal, viral, and protozoal infections.

Antimicrobial agents act by inhibiting the growth or killing the microorganisms responsible for infections. They target specific cellular components or processes within the microbes, disrupting their vital functions and preventing their proliferation. These agents can be further classified based on their mechanism of action, such as bactericidal (kills bacteria) or bacteriostatic (inhibits bacterial growth).

The development of new antimicrobial agents is a continuous process due to the increasing threat of drug resistance. Pharmaceutical companies invest significant resources in research and development to discover and design novel compounds with improved efficacy and reduced side effects.

Several types of antimicrobial agents are available, including beta-lactams, macrolides, fluoroquinolones, aminoglycosides, and tetracyclines. Each class exhibits a distinct mode of action, making them suitable for treating specific types of infections. Additionally, combination therapies involving multiple antimicrobial agents are often employed to enhance effectiveness and combat resistance.

Antimicrobial agents are utilized not only in human medicine but also in veterinary and agricultural sectors to maintain the health and well-being of animals and plants. Strict regulations and quality control measures are in place to ensure the safety and efficacy of these pharmaceutical APIs.

In conclusion, antimicrobial agents are a crucial subcategory of pharmaceutical APIs that play a pivotal role in fighting microbial infections. Continuous research and development efforts are necessary to combat emerging drug resistance and ensure the availability of effective treatments for various infections.

Iodine povacrylex (Antimicrobial agents), classified under Anti-infective Agents

Anti-infective agents are a vital category of pharmaceutical active pharmaceutical ingredients (APIs) used in the treatment of various infectious diseases. These agents play a crucial role in combating bacterial, viral, fungal, and parasitic infections. The demand for effective anti-infective APIs has grown significantly due to the increasing prevalence of drug-resistant microorganisms.

Anti-infective APIs encompass a wide range of substances, including antibiotics, antivirals, antifungals, and antiparasitics. Antibiotics are particularly important in fighting bacterial infections and are further categorized into different classes based on their mode of action and target bacteria. Antivirals are designed to inhibit viral replication and are essential in the treatment of viral infections such as influenza and HIV. Antifungals combat fungal infections, while antiparasitics are used to eliminate parasites that cause diseases like malaria and helminthiasis.

The development and production of high-quality anti-infective APIs require stringent manufacturing processes and adherence to regulatory standards. Pharmaceutical companies invest heavily in research and development to discover new and more effective anti-infective agents. Additionally, ensuring the safety, efficacy, and stability of these APIs is of utmost importance.

The global market for anti-infective APIs is driven by factors such as the rising incidence of infectious diseases, the emergence of new and drug-resistant pathogens, and the growing demand for improved healthcare infrastructure. Continuous advancements in pharmaceutical technology and the development of innovative drug delivery systems further contribute to the expansion of this market.

In conclusion, anti-infective agents are a critical category of pharmaceutical APIs that play a pivotal role in treating infectious diseases. Their effectiveness in combating various types of infections makes them essential components in the arsenal of modern medicine.